OrbiMed’s CAREFUSION CORPORATION CFN Stock Holding History

OrbiMed’s Portfolio CFN Stock Details CFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-250,000	Closed	-$10.1M	–	153
2014 Q1	$10.1M	Buy	+250,000	New	+$10.1M	0.12%	91

Other funds holding CFN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

OrbiMed's CFN Position: Q4 2014 in Review

OrbiMed sold out of CAREFUSION CORPORATION (CFN) in Q4 2014, closing a stake of 4,756,000 shares — an estimated $215M sold.

OrbiMed first reported a position in CFN in Q2 2013 and held it in 6 quarters. The position peaked at $215M in Q3 2014. 449 funds tracked by Wall St. Rank hold CFN as of Q4 2014.

OrbiMed reported no remaining CAREFUSION CORPORATION position as of Q4 2014 after selling out during the quarter.
OrbiMed sold 4,756,000 CAREFUSION CORPORATION shares in Q4 2014, an estimated $215M.
OrbiMed first reported a position in CAREFUSION CORPORATION in Q2 2013 and held it in 6 quarters.
OrbiMed's CAREFUSION CORPORATION position peaked at $215M in Q3 2014.
449 funds tracked by Wall St. Rank held CAREFUSION CORPORATION as of Q4 2014.

Based on OrbiMed's 13F filing for Q4 2014, filed 13 Feb 2015.